Institutional investors purchased a net $151.1 thousand shares of BIOC during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 4.99% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EDGE WEALTH MANAGEMENT LLC Sold 2.0 Thousand shares of Biocept Inc